eLaws | eCases | United States Code | Federal Courts |

2019-18324. Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.

Start Preamble
ACTION:

Notice of application.

DATES:

Registered bulk manufacturers of the affected basic classes, and Start Printed Page 44640applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 25, 2019.

ADDRESS:

Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental Information
SUPPLEMENTARY INFORMATION:

In accordance with 21 CFR 1301.33(a), this is notice that on June 19, 2019, Cambrex High Point, Inc., 4180 Mendenhall Oaks Parkway, High Point, North Carolina 27265-8017 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Controlled substance Drug code Schedule
Oxymorphone 9652 II
Noroxymorphone 9668 II

The company plans to manufacture the above listed controlled substances in bulk for distribution to its customers. No other activities for these drug codes are authorized for this registration.
Start Signature

Dated: August 9, 2019.

Neil D. Doherty,

Acting Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2019-18324 Filed 8-23-19; 8:45 am]

BILLING CODE 4410-09-P

Visit the Official Version

Leave a Comment

Document Information

Published:: 08/26/2019
Department:: Drug Enforcement Administration
Entry Type:: Notice
Action:: Notice of application.
Document Number:: 2019-18324
Dates:: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before October 25, 2019.
Pages:: 44639-44640 (2 pages)
Docket Numbers:: Docket No. DEA-392
PDF File:: 2019-18324.pdf